FASN and cancer: Usually overexpressed in cancer cells, FASN downregulation could be associated with the switch of MCF7 cancer cells between a proliferating state to a migratory behavior that is based on an exogenous uptake of fatty acids and FAs release from cell membranes rather than an intracellular de novo synthesis of FAs.